Profil
Orville G.
Kolterman is currently a Director at the American Diabetes Association Research Foundation, Inc., GlySens, Inc., and a Member at the National Institute of Diabetes & Digestive & Kidney Diseases.
He was previously a Director at ViaCyte, Inc., the Medical Director-Diabetes Center at the University of California San Diego, Chief Medical Officer & Senior Vice President at Amylin Pharmaceuticals, Inc., and President at the American Diabetes Association.
He was also an Assistant Professor at The University of Colorado School of Medicine.
Dr. Kolterman holds a doctorate degree from Stanford University School of Medicine.
Aktive Positionen von Orville G. Kolterman
| Unternehmen | Position | Beginn |
|---|---|---|
National Institute of Diabetes & Digestive & Kidney Diseases
National Institute of Diabetes & Digestive & Kidney Diseases General GovernmentGovernment Engages in clinical research on serious diseases | Corporate Officer/Principal | - |
GlySens, Inc.
GlySens, Inc. Medical SpecialtiesHealth Technology Develops glucose monitoring system | Direktor/Vorstandsmitglied | 27.10.2011 |
American Diabetes Association Research Foundation, Inc. | Direktor/Vorstandsmitglied | 27.10.2011 |
Ehemalige bekannte Positionen von Orville G. Kolterman
| Unternehmen | Position | Ende |
|---|---|---|
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Direktor/Vorstandsmitglied | 29.01.2019 |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.01.1992 |
The University of Colorado School of Medicine
The University of Colorado School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.01.1983 |
American Diabetes Association
American Diabetes Association Miscellaneous Commercial ServicesCommercial Services Provides diabetes related medical services | Präsident | - |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Orville G. Kolterman
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Health Technology |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Diabetes Association
American Diabetes Association Miscellaneous Commercial ServicesCommercial Services Provides diabetes related medical services | Commercial Services |
National Institute of Diabetes & Digestive & Kidney Diseases
National Institute of Diabetes & Digestive & Kidney Diseases General GovernmentGovernment Engages in clinical research on serious diseases | Government |
American Diabetes Association Research Foundation, Inc. | |
GlySens, Inc.
GlySens, Inc. Medical SpecialtiesHealth Technology Develops glucose monitoring system | Health Technology |
Stanford University School of Medicine
Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Colorado School of Medicine
The University of Colorado School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















